HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephanie Burke Selected Research

Neoplasms (Cancer)

1/2017Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
8/2014Differential expression of miRNAs in colon cancer between African and Caucasian Americans: implications for cancer racial health disparities.
1/2014Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells.
12/2011Prognostic significance of miR-215 in colon cancer.
10/2011Differential expression of transferrin receptor (TfR) in a spectrum of normal to malignant breast tissues: implications for in situ and invasive carcinoma.
6/2010p16(INK4a) is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephanie Burke Research Topics

Disease

6Neoplasms (Cancer)
01/2017 - 06/2010
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 04/2014
2Noninfiltrating Intraductal Carcinoma (DCIS)
01/2016 - 10/2011
2Colonic Neoplasms (Colon Cancer)
08/2014 - 12/2011
2Squamous Intraepithelial Lesions
04/2014 - 06/2010
2Carcinoma (Carcinomatosis)
01/2014 - 10/2011
1Squamous Cell Carcinoma of Head and Neck
01/2018
1Lobular Carcinoma
01/2017
1Breast Neoplasms (Breast Cancer)
01/2017
1Ductal Carcinoma
01/2017
1Stomach Neoplasms (Stomach Cancer)
03/2016
1Colorectal Neoplasms (Colorectal Cancer)
08/2014
1Carcinogenesis
01/2014
1Adenocarcinoma
02/2012
1Uterine Cervical Dysplasia
06/2010
1Atypical Squamous Cells of the Cervix
06/2010

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
01/2018 - 12/2011
4Proteins (Proteins, Gene)FDA Link
01/2017 - 12/2011
3Keratin-17 (Keratin 17)IBA
01/2018 - 04/2014
3Estrogen ReceptorsIBA
01/2017 - 10/2011
2MicroRNAs (MicroRNA)IBA
03/2016 - 08/2014
2RNA (Ribonucleic Acid)IBA
08/2014 - 01/2014
2Cyclin-Dependent Kinase Inhibitor p16IBA
02/2012 - 06/2010
1Keratins (Keratin)IBA
01/2017
1Epidermal Growth Factor (EGF)IBA
01/2017
1Progesterone Receptors (Progesterone Receptor)IBA
01/2017
1Messenger RNA (mRNA)IBA
01/2017
1human ERBB2 proteinIBA
01/2017
1SurvivinIBA
01/2016
1Cyclin D1IBA
01/2016
1Caveolin 1IBA
01/2016
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2016
1Keratin-4 (Keratin 4)IBA
04/2014
1Formaldehyde (Formol)FDA Link
04/2014
1ParaffinIBA
04/2014
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2014
1NF-kappa B (NF-kB)IBA
01/2014
1Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA
12/2011
1Thymidylate SynthaseIBA
12/2011
1trizolIBA
12/2011
1Transferrin Receptors (Transferrin Receptor)IBA
10/2011
1IronIBA
10/2011

Therapy/Procedure

1Therapeutics
01/2014
1Transplantation
01/2014